Efficient synthesis of enantiomeric pairs of thiolactomycin and its 3-demethyl derivative

Tetrahedron Letters

Volumn 47, Issue 16, 2006, Pages 2787-2791

  Ohata, Kohei ^a   Terashima, Shiro ^b  

^a KYORIN PHARMACEUTICAL CO LTD   (Japan)

^b SAGAMI CHEMICAL RESEARCH CENTER   (Japan)

Author keywords

Antibiotic; Deconjugative asymmetric sulfenylation; Inhibitor of fatty acid synthase

Indexed keywords

3 DEMETHYL DERIVATIVE; ALDEHYDE; THIOLACTOMYCIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MYCOBACTERIUM TUBERCULOSIS; PROTON NUCLEAR MAGNETIC RESONANCE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 33644977648     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.02.058     Document Type: Article

References (31)

1. H. Oishi, T. Noto, H. Sasaki, K. Suzuki, T. Hayashi, H. Okazaki, K. Ando, and M. Sawada J. Antibiot. 35 1982 391 395
2. T. Noto, S. Miyakawa, H. Oishi, H. Endo, and H. Okazaki J. Antibiot. 35 1982 401 410
3. S. Miyakawa, K. Suzuki, T. Noto, Y. Harada, and H. Okazaki J. Antibiot. 35 1982 411 419
4. L. Kremer, J.D. Douglas, A.R. Baulard, C. Morehouse, M.R. Guy, D. Alland, L.G. Dover, J.H. Lakey, W.R. Jacobs, P.J. Brennan, D.E. Minnikin, and G.S. Besra J. Biol. Chem. 275 2000 16857 16864
5. R.A. Slayden, R.E. Lee, J.W. Armour, A.M. Cooper, I.M. Orme, P.J. Brennan, and G.S. Besra Antimicrob. Agents Chemother. 40 1996 2813 2819
6. R.F. Waller, S.A. Ralph, M.B. Reed, V. Su, J.D. Douglas, D.E. Minnikin, A.F. Cowman, G.S. Besra, and G.I. McFadden Antimicrob. Agents Chemother. 47 2003 297 301
7. S.M. Jones, J.E. Urch, R. Brun, J.L. Harwood, C. Berry, and I.H. Gilbert Bioorg. Med. Chem. 12 2004 683 692
8. S. Jackowski, C.M. Murphy, J.E. Cronan, and C.O. Rock J. Biol. Chem. 264 1989 7624 7629
9. A.C. Price, K.-H. Choi, R.J. Heath, Z. Li, S.W. White, and C.O. Rock J. Biol. Chem. 276 2001 6551 6559
10. T. Hayashi, O. Yamamoto, H. Sasaki, A. Kawaguchi, and H. Okazaki Biochem. Biophys. Res. Commun. 115 1983 1108 1113
11. I. Nishida, A. Kawaguchi, and M. Yamada J. Biochem. (Tokyo) 99 1986 1447 1454
12. J.M. McFadden, S.M. Medghalchi, J.N. Thupari, M.L. Pinn, A. Vadlamudi, K.I. Miller, F.P. Kuhajda, and C.A. Townsend J. Med. Chem. 48 2005 946 961
13. C.L. Wang, and J.M. Salvino Tetrahedron Lett. 25 1984 5243 5246
14. M.S. Chambers, E.J. Thomas, and D.J. Williams J. Chem. Soc., Chem. Commun. 1987 1228 1230
15. M.S. Chambers, and E.J. Thomas J. Chem. Soc., Chem. Commun. 1989 23 24
16. M.S. Chambers, and E.J. Thomas J. Chem. Soc., Perkin Trans. 1 1997 417 431
17. J.M. McFadden, G.L. Frehywot, and C.A. Townsend Org. Lett. 4 2002 3859 3862
18. Deconjugative asymmetric allylation of a dienolate with formation of a quarternary asymmetric center has been recently reported by Kobayashi et al. T. Abe, T. Suzuki, K. Sekiguchi, S. Hosokawa, and S. Kobayashi Tetrahedron Lett. 44 2003 9303 9305
19. D.A. Evans, T.C. Britton, J.A. Ellman, and R.L. Dorow J. Am. Chem. Soc. 112 1990 4011 4030
20. According to the procedure reported by Fujiki et al., 6 was prepared from 3-bromopropionaldehyde dimethylacetal (i ) as shown below. K. Fujiki, N. Tanifuji, Y. Sakaki, and T. Yokoyama Synthesis 2002 343 348
21. R.J. Petroski, and D. Weisleder Synth. Commun. 31 2001 89 95
22. G.J. Ho, and D.J. Mathre J. Org. Chem. 60 1995 2271 2273
23. 4p-Me) underwent deconjugative asymmetric α-sulfenylation similar to 1, the methylsulfenyl and the (2-trimethylsilyl)ethylsulfenyl group introduced into the reaction products could not be elaborated to a thiol or an acylsulfenyl group.
24. R 14.7 min (5), 10.4 min [the (3′Z)-isomer of 5 ], 25.1 min (11 )].
25. +H): 434.2001. Found 434.1967.
26. The structure of the (3′Z)-isomer of 5 was determined by NOESY spectrum which was observed between C-3′ H and C-4′ Me.
27. Taking into account its electronic and steric effects, it is anticipated that I can participate in the reaction more preferentially than II. See: S. Hosokawa, K. Sekiguchi, M. Enemoto, and S. Kobayashi Tetrahedron Lett. 41 2000 6429 6433
28. R 11.0 min (1 ), 14.9 min (ent-1 ). Daicel Chiralcel OJ ∅0.46 cm × 25 cm, hexane/EtOH/TFA = 99:1:0.1, flow rate 1.0 mL/min, 17.9 min (2 ) and 22.5 min (ent-2 ) detection at 238 nm).
29. 20).
30. H. Sasaki, H. Oishi, T. Hayashi, I. Matsuura, K. Ando, and M. Sawada J. Antibiot. 35 1982 396 400
31. Antibacterial activity of 1, ent-1, 2 and ent-2 were 128 μg/mL, >128 μg/mL, >128 μg/mL and >128 μg/mL against S. aureus and 0.25 μg/mL, >128 μg/mL, 16 μg/mL and >128 μg/mL against. M. catarrhalis, respectively. Evaluation of the inhibitory activity of those compounds against FAS is in progress.